Table 2.

Hazard Ratios with 95% CI based on the Cox proportional hazard regression model for EFS and OS.

	EFS		OS
	Hazard Ratio	95% CI	Hazard Ratio	95% CI
RNA panel: PB and/or BM positive	9.52	3.23–28.02	Not possible due to low number of events in Standard Risk group
Standard Risk	1
High Risk	1.15	0.35–3.83
Metastatic disease	1.52	0.50–4.66
RNA panel: PB and/or BM positive	8.83	3.38–23.10	7.13	2.19–23.18
Positive BM immunohistochemistry	0.91	0.33–2.54	1.22	0.37–3.98
RNA panel: PB and/or BM positive	6.98	2.58–18.85	4.48	1.32–15.15
Metastatic disease	1.69	0.72–3.98	3.70	1.23–11.16
RNA panel: PB and/or BM positive	7.71	2.85–20.89	5.91	1.71–20.45
Alveolar rhabdomyosarcoma	1.29	0.55–3.02	1.66	0.57–4.85
RNA panel: PB and/or BM positive	8.22	3.25–20.78	6.21	2.00–19.28
Age > 10 years	2.07	0.93–4.61	5.65	1.92–16.59
RNA panel: PB and/or BM positive	7.80	2.89–21.01	4.27	1.23–14.87
Regional lymph node involvement	1.17	0.50–2.78	3.29	1.06–10.18
RNA panel: PB and/or BM positive	6.63	2.53–17.38	4.20	1.33–13.24
Tumor size >5 cm	2.33	0.83–6.54	9.57	1.21–75.84